PubRank

Osvaldo L Podhajcer

Author PubWeight™ 25.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004 2.46
2 SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth. J Invest Dermatol 2007 1.51
3 Model based analysis of real-time PCR data from DNA binding dye protocols. BMC Bioinformatics 2007 1.50
4 p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. J Cell Sci 2008 1.24
5 Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway. J Cell Biochem 2008 1.05
6 Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J Gene Med 2008 0.94
7 Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res 2005 0.94
8 SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated. Int J Cancer 2008 0.93
9 A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice. Mol Ther 2012 0.90
10 SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis. J Invest Dermatol 2011 0.88
11 IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasis. J Immunol 2005 0.88
12 Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells. Int J Cancer 2010 0.87
13 Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment. J Invest Dermatol 2013 0.87
14 Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol Carcinog 2004 0.87
15 Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses. PLoS One 2008 0.85
16 Gene therapy for autoimmune diseases: quo vadis? Nat Rev Immunol 2004 0.85
17 A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus. Stem Cells Dev 2012 0.85
18 A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Clin Cancer Res 2009 0.82
19 Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter. Mol Ther 2009 0.81
20 Amyloid peptides ABri and ADan show differential neurotoxicity in transgenic Drosophila models of familial British and Danish dementia. Mol Neurodegener 2014 0.81
21 A novel hybrid promoter responsive to pathophysiological and pharmacological regulation. J Mol Med (Berl) 2011 0.80
22 The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer. Int J Cancer 2013 0.79
23 The multi-reference contrast method: facilitating set enrichment analysis. Comput Biol Med 2012 0.76
24 Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence. Mol Ther 2013 0.76
25 Platelet-endothelial cell adhesion molecule-1 (CD31) recycles and induces cell growth inhibition on human tumor cell lines. J Cell Biochem 2006 0.76
26 Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth. Mol Cancer Ther 2006 0.76
27 Improving 2D-DIGE protein expression analysis by two-stage linear mixed models: assessing experimental effects in a melanoma cell study. Bioinformatics 2008 0.75
28 Current status of stem cells and regenerative medicine research in Argentina. Stem Cells Dev 2014 0.75